Chelsea Green Publishing

The Blogging Community at Chelsea Green

DEA Enacts Federal Ban On ‘Marijuana-Like’ Herbal Products Sold Over The Counter

The United States Drug Enforcement Administration (DEA) today, as anticipated, exercised its ‘emergency scheduling authority’ to criminally prohibit the possession and sale of chemical agents contained in so-called ‘fake’ herbal marijuana products, commonly sold over the counter under the brand names ‘K2’ and ‘Spice.’ The agency had initially announced its intent to outlaw the chemicals last November. The specific compounds prohibited under the new DEA ban are: JWH-018, JWH-073, JWH-200, CP-47,497, and cannabicyclohexanol. Each of these compounds is now placed in the same category as heroin under federal law. “Except as authorized by law, this action makes possessing and selling these chemicals or the products that contain them illegal in the United States,” the DEA stated in a press release. “This emergency action was necessary to prevent an imminent threat to public health and safety.” The agency says that the federal ban will remain in effect for at least one year while the DEA and the United States Department of Health and Human Services (DHHS) “further study whether these chemicals should be permanently controlled.” The chemicals in question are synthetic cannabinoid agonists. Once ingested, they interact with endogenous cannabinoid receptors to elicit certain physical and euphoric effects associated with the ingestion of marijuana. They are added to inert herbs to temporarily induce euphoria in the user. Though NORML takes no official position regarding the use or regulation of these synthetic products, NORML Deputy Director Paul Armentano issued the following statement:
“The popularity of these products is a predictable outgrowth of criminal marijuana prohibition. As prohibition is apt to do, it has driven the production of a commodity into the hands of unregulated, unknown dealers, driven up the potency of the commodity, and in doing so created a scenario where the consumer is faced with a potentially greater health risks than they would be had they simply had the legal choice to use the product they actually desired, in this case cannabis. “Since most manufacturers of these products reside overseas and are not subject to federal laws and regulations, it is unlikely that the DEA’s action – as well as the similar bans in other states – will in any way halt the dissemination, use, or misuse of these products by the public. Most likely, the clamp down will likely only make the situation more dangerous – from both a legal standpoint and from a health standpoint – to the consumer.
Read the original article on the NORML blog.
marijuanaissafer Paul Armentano is the author of Marijuana Is Safer: So Why Are We Driving People To Drink?.


Federal Cannabis Prohibition Turned 75-Years-Old on October 1

In a milestone that will no doubt go largely unnoticed by the mainstream media, today marks the 75th anniversary of the enactment of federal marijuana prohibition. On October 1, 1937, the US government criminally outlawed the possession and cultivation of cannabis — setting into motion a public policy that today results in some 850,000 arrests […] Read More..

Montana: Supreme Court Says Patients Possess No Fundamental Right To Cannabis

Members of the Montana Supreme Court ruled 6 to 1 on Tuesday that patients do not possess a fundamental right to access and consume cannabis for therapeutic purposes. The decision reverses a District Court ruling enjoining the state from enforcing various provisions of a 2011 state law that limits the public’s access to medical marijuana. […] Read More..

Study: Non-Psychotropic Cannabinoid “Proven To Be Safe” In Humans

The oral administration of the non-psychotropic cannabis plant constituent cannabidiol (CBD) is safe and well tolerated in humans, according to clinical trial data published online by the journal Current Pharmaceutical Design. Investigators at Kings College in London assessed the physiological and behavioral effects of CBD and THC versus placebo in 16 healthy volunteers in a […] Read More..

Michigan: Grand Rapids Voters Will Decide On $25 Fine-Only Offense For Pot Possession

Voters in Grand Rapids, Michigan will decide this November on a municipal measure to depenalize marijuana possession offenses to a non-criminal, fine-only offense. The City Commissioner’s office has approved the measure, Proposal 2, which seeks to allow local law enforcement the discretion to ticket first-time marijuana offenders with a civil citation, punishable by a $25 […] Read More..

Scientific Review: “There Is Now Clear Evidence That Cannabinoids Are Useful For The Treatment Of Various Medical Conditions”

For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law, which states that the plant and its organic constituents possess a “high potential for abuse,” and that they lack “accepted medical use” and “accepted safety … […] Read More..